Doseloop Beta

Venlafaxine

medication Under review

A serotonin-norepinephrine reuptake inhibitor (SNRI) commonly used to treat depression and anxiety disorders.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence on venlafaxine in healthy human subjects is sparse, with most research focused on its neuroendocrine effects rather than broad health benefits. A single key study in healthy males showed dose-dependent increases in prolactin and growth hormone without significant cortisol changes, indicating selective hormonal modulation. Overall consensus highlights its pharmacological action on monoamines but lacks robust data on benefits for healthy adults, as trials predominantly involve patients with conditions like depression. Adverse effects are better documented, with higher rates of non-serious events like sexual dysfunction and anorexia in comparative analyses, though these derive from patient populations. No strong evidence supports routine use in healthy humans, and growth impacts observed in pediatric studies raise caution for long-term application.

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (2 studies)

Systematic Review

The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review with trial sequential analysis and network meta-analysis

BMC Psychiatry • 2024 • n=6253

Kahlert J, et al.

RCT

20-699, SE5-030: Effexor (venlafaxine HCl) Tablets - FDA Clinical BPCA Review

FDA Supplemental New Drug Application Review • 2007 • n=161

FDA Review Team

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 2
Researched benefits 0
Side effects noted 1